[Effect of anticoagulant therapy on the patency of aorto-coronary bypass graft (author's transl)]. 1981

T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
November 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
January 1980, Giornale italiano di cardiologia,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
June 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
November 1980, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
January 1978, L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
February 1978, Kokyu to junkan. Respiration & circulation,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
January 1975, Giornale italiano di cardiologia,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
September 1983, Circulation,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
September 1982, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
T Sasaki, and H Yokoyama, and T Yamaguchi, and K Yoshino, and H Kagaya
January 1981, La Nouvelle presse medicale,
Copied contents to your clipboard!